Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
TDOC
HoldBargain BinFLAGTeladoc Health, Inc. · Healthcare · United States · $1.2B · Avg Vol: $30M/d
Teladoc Health has strong momentum M72 and quality exactly at Q51, but value at V49 is below the calibrated floor, and insiders sold, so stage one fails.
COMPANY DESCRIPTION
Teladoc Health, Inc. is a global leader in virtual healthcare services, providing on-demand and scheduled consultations with doctors, therapists, and specialists via phone, video, or app for a comprehensive range of services. The company benefits from its extensive network of healthcare providers, advanced telehealth platform, and strategic partnerships with health plans and employers. It is the world's largest virtual care provider, at the forefront of digital health innovation, offering a holistic approach to healthcare delivery.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 2.4B | 2.6B | 2.6B | 2.5B | 1.7% | 2.5B | 2.4B | 2.4B | -2.7% |
| EPS | -2.73 | -84.60 | -1.34 | -5.87 | -1.14 | — | -0.99 | -0.78 | -0.79 | — |
| Shares | — | 162.8M | 166.7M | 173.4M | 178.3M | +9.5% | 181.7M | — | — | — |
| Debt | — | 1.6B | 1.6B | 1.6B | 1.0B | -13.1% | 1.0B | — | — | — |
| Equity | — | 2.3B | 2.3B | 1.5B | 1.4B | -15.6% | — | — | — | — |
| Op CF | — | 189.3M | 350.0M | 293.7M | 294.4M | 15.9% | 261.2M | — | — | — |
| Inv CF | — | -167.7M | -156.3M | -124.1M | -266.0M | — | — | — | — | — |
| Fin CF | — | 6.5M | 10.9M | 8.3M | -551.7M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of TDOC are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| TDOC | Teladoc Health, Inc.(you) | $1.2B | 49 | Hold |
| CERT | Certara, Inc. | $1.3B | 48 | Hold |
| PHR | Phreesia, Inc. | $751M | 48 | Hold |
| SDGR | Schrödinger, Inc. | $1.5B | 36 | Hold |
| PRVA | Privia Health Group, Inc. | $2.7B | 51 | Hold |
| MDRX | Veradigm Inc. | $517M | 51 | Hold |
| OMDA | Omada Health, Inc. | $1.5B | 65 | Buy |
| EVH | Evolent Health, Inc. | $520M | 43 | Hold |
| OMCL | Omnicell, Inc. | $1.5B | 66 | Buy |
| CARL | Carlsmed, Inc. | $461M | 40 | Hold |
Peer medians: ROE -30.8% · P/E 27.0x · Gross margin 58.1%